Affiliation:
1. Zhejiang University of Technology
Abstract
S-licarbazepine was synthesized by asymmetric reduction of oxcarbazepine in organic solvent/phosphate buffer biphasic system with Bacillus anthracis CGMCC No.12337 as catalyst. Effects of many factors on reduction were studied. Dibutyl phthalate/phosphate buffer was selected as the optimal biphasic system for reduction. The optimum reduction conditions are as follows: volume ratio of dibutyl phthalate and phosphate buffer 1:1, 30 g/L iospropanol as co-substrate, phosphate buffer pH 5, substrate concentration 7.92 mmol/L, cell concentration 30 g/L, 32°C,180 rpm. The conversion and enantiometric excess of S-licarbazepine reached 97.32% and 99.80%. An efficient method for synthesis of S-licarbazepine was provided.
Publisher
Trans Tech Publications, Ltd.
Subject
Mechanical Engineering,Mechanics of Materials,Condensed Matter Physics,General Materials Science
Reference10 articles.
1. C.J. Landmark, P.N. Patsalos, Drug interactions involving the new second- and third-generation antiepileptic drugs, Expert Review Neurotherapeutics. 10 (2014) 119-140.
2. Z.F. Rao, W.G. Fang, Recent development of Eslicarbazepine acetate, a new drug against epilepsy, J. Chin Pharm. 18 (2015) 471-473.
3. D.A. Lozsadi, J.V Oertzen, H.R. Cock, Epilepsy: recent advances, J Neurology. 257 (2010) 1946-(1951).
4. M. Singh, S. Singh, S. Deshaboina, H. Krishnen, R. Lloyd, Asymmetric reduction of a key intermediate of eslicarbazepine acetate using whole cell biotransformation in a biphasic medium, Catal Sci Technol. 2 (2012) 1602-1605.
5. L.L. Zhao, X.L. Du, A novel antiepileptic drug-eslicarbazepine acetate, Chin J New Drugs. 23 (2014) 2461-2464.